Aldosterone controls sodium balance by regulating an epithelial sodium channel (ENaC)-mediated sodium transport along the aldosterone-sensitive distal nephron, which expresses both mineralocorticoid (MR) and glucocorticoid receptors (GR). Mineralocorticoid specificity is ensured by 11␤-hydroxysteroid dehydrogenase type 2, which metabolizes cortisol or corticosterone into inactive metabolites that are unable to bind MR and/or GR. The fractional occupancy of MR and GR by aldosterone mediating the sodium transport response in the aldosterone-sensitive distal nephron cannot be studied in vivo. For answering this question, a novel mouse cortical collecting duct cell line (mCCD cl1 ), which expresses significant levels of MR and GR and a robust aldosterone sodium transport response, was used. Aldosterone elicited a biphasic response: Low doses (K 1/2 ‫؍‬ approximately 0.5 nM) induced a transient and early increase of sodium transport (peaking at 3 h), whereas high doses (K 1/2 ‫؍‬ approximately 90 nM) entailed an approximately threefold larger, long-lasting response. At 3 h, the corticosterone doseresponse curve was shifted to the right compared with that of aldosterone by more than two log concentrations, an effect that was fully reverted in the presence of the 11␤-hydroxysteroid dehydrogenase type 2 inhibitor carbenoxolone. Low doses of dexamethasone (0.1 to 1 nM) failed to induce an early response, but high doses elicited a long-lasting response (K 1/2 ‫؍‬ approximately 8 nM), similar to that observed for high aldosterone concentrations. Equilibrium binding assays showed that both aldosterone and corticosterone bind to a high-affinity, low-capacity site, whereas dexamethasone binds to one site. Within the physiologic range of aldosterone concentrations, sodium transport is predicted to be controlled by MR occupancy during circadian cycles and by MR and GR occupancy during salt restriction or acute stress.
T ransepithelial Na
ϩ and K ϩ transports are regulated by mineralocorticoid hormones in the aldosterone-sensitive distal nephron (ASDN), in the distal colon, and in other epithelia characterized by a high transmural electrical resistance ("tight" epithelia) and an amiloride-sensitive, electrogenic sodium transport (1) . The resulting changes in urinary Na ϩ and K ϩ excretion are responsible for the regulation of the sodium and potassium balance of the organism. In vivo, the early effect of aldosterone was observed in adrenalectomized rats with a latent period of approximately 30 min and was fully inhibited by Actinomycin D (2, 3) . The genomic action of aldosterone is a three-step mechanism: (1) binding to its cognate receptor followed by its translocation into the nucleus; (2) binding of the liganded receptor to hormonal regulatory elements situated on the promoter of a selected number of genes, leading to transcription activation or repression (aldosterone induced-
[AIT] or -repressed transcripts [ART]); and (3) translation into their respective aldosterone-induced (AIP) or -repressed proteins (ARP) mediating in turn the upregulation of amiloridesensitive electrogenic sodium transport (1) . In its target cell, aldosterone is known to bind to two types of binding sites (4): a high-affinity, type 1 binding site (K d ϭ approximately 0.5 to 2 nmol/L), and a low-affinity (K d ϭ approximately 14 to 60 nmol/L), type 2 binding site (5-7), which have been tentatively identified with the proteins known as the mineralocorticoid (MR) and glucocorticoid (GR) receptors, respectively. Corticosterone (or cortisol) binds with the same affinity as aldosterone to type 1 binding site and a higher affinity to type 2 binding site. Dexamethasone has a high affinity for type 2 binding site and a lower affinity for type 1. In an earlier work in the toad bladder system, we established a quantitative correlation between occupancy of type 1 (MR) versus type 2 (GR) receptor, with the early versus late response to aldosterone (8) . We concluded that occupancy of both type 1 (MR) and type 2 (GR) was necessary to achieve maximal sodium transport across this tight epithelia. Occupancy of type 1 receptor was related mainly to the early phase of aldosterone action, whereas the late response correlated with occupancy of type 2 receptor. The limitations of the toad bladder system were significant: (1) a detailed dose-response curve could not be technically achieved, (2) the effects of glucocorticoid agonist or antagonist were not studied, (3) the relevance of the amphibian model to the function of the mammalian cortical collecting duct was uncertain, and (4) the 11␤-hydroxysteroid dehydrogenase type 2 (11␤-HSD2) mechanism was not yet known. Mineralocorticoid specificity is indeed achieved by the presence of 11␤-HSD2, an enzyme that metabolizes cortisol into cortisone (or corticosterone into 11␤-dehydrocorticosterone) with only 0.3% affinity to MR receptor (9, 10) . The enzyme has a high V max in cortical collecting duct (CCD) cells so that the MR should be protected from illicit occupation by free plasma cortisol (or corticosterone), which may circulate at Ͼ100-fold excess over aldosterone in the plasma. The model predicts that GR could be occupied by aldosterone, but the physiologic relevance of this binding for mediating the sodium transport response is not known. To address this question and to study the respective role of aldosterone and glucocorticoids as well as their cognate receptors for sodium transport by the ASDN, we took advantage of a novel spontaneously transformed cell line derived from CCD primary cultures. Our principal aims were to establish (1) a quantitative correlation of MR versus GR occupancy with the sodium transport response for agonist (aldosterone, corticosterone, and dexamethasone) and in the presence of MR antagonist (spironolactone) or GR antagonist (RU486) and (2) the role of the 11␤-HSD2 in the protection of MR in vitro. This enabled us to correlate the physiologic variations of plasma corticosteroid in function of the circadian rhythm and the salt intake and their pathophysiologic variations during stress and hypovolemia, with the predicted occupancy of MR or GR. 3 was removed, filters were preincubated with growth medium (1.5 ml apical and 2.5 ml basolateral) for 24 h, and seeding was performed using fresh medium.
Materials and Methods

Materials
Culture Media
Growth medium was DMEM supplemented with insulin (0.87 M), human apotransferrin (5 g/ml), EGF (10 ng/ml), T3 (1 nM) dexamethasone (50 nM), penicillin (100 /ml), streptomycin (130 g/ml), and 2% FCS. Filter cup medium was DMEM supplemented with 3 nM dexamethasone.
Establishment of the mCCD cl1 Cell Line
The generation of the Liddle mice has been described previously (11) . For in vitro primary cell culture experiments, L/L, L/ϩ, and ϩ/ϩ littermates were used. Confluent primary cultures of CCD microdissected from kidney ␤ENaC ϩ/ϩ, L/ϩ, and L/L mice were grown in growth medium, according to the previously described method (12, 13) . More than 60 primary cultures from each genotype were dissociated in EDTA trypsin solution and seeded on 96-tissue culture dishes. Cells were passaged every other week, and a number of single clones that spontaneously went on dividing beyond five passages could be isolated from either genotype. In the present article, we describe one clone of wild-type origin that we term mCCD cl1 .
Electrophysiologic Studies
Confluent cells that were seeded and grown in growth medium on collagen-coated Transwells for 5 d then were grown for another 5 Corticosteroid Binding Assay mCCD cl1 were grown until confluence in 100-mm Petri dishes (7 d), incubated for 2 h in a Ringer solution (143 mM NaCl, 17.5 mM NaHCO 3 , 4 mM KCl, 0.8 mM KH 2 PO 4 , 10 mM glucose, 1 mM and CaCl 2 ), then rinsed in fresh Ringer solution for another 2 h and then gently scraped off the dishes, centrifuged for 5 min at 150 ϫ g, and the pellet snap-frozen in liquid nitrogen. The cells were homogenized by grinding them under liquid nitrogen. The powder was diluted threefold with buffer (220 mM sucrose, 10 mM TES, 12 mM Thioglycerol, 25 mM KCl, and 1.5 mM EDTA adjusted to a pH of 7.0), complemented with 1 mM dithiothreitol, then centrifuged for 7 min at 48,000 ϫ g. Cell cytosol preparations were complemented with 10 mM Na-Molybdate and immediately used for steroid binding assays (14) or frozen in liquid nitrogen for further use. Aliquots of cytosol (130 l) were incubated with 0.1 to 670 nM ( 3 H)aldosterone, ( 3 H)corticosterone, or ( 3 H)dexamethasone for 4 h at 4°C. Bound and free hormones were separated, using the dextran-charcoal method, and bound hormone was analyzed as a function of free hormone, using the Ligand software for fitting one or two binding-sites Ϯ nonspecific binding. In a separate experiment, corticosteroid binding assay was performed on cells that had been grown on large Costar Transwell (50 cm 2 ) and grown until development of a basal sodium transport and a high transepithelial electrical resistance (5 to 10 M/cm 2 and up to 8000 Ohm/cm 2 ). 
Immunofluorescence Cells that were grown on permeable support were prepared for immunofluorescence, as described previously (15) . The epithelial sodium channel (ENaC) (16) and Na-K-ATPase (17) antibodies were previously described. Cells were fixed with 3% paraformaldehyde in PBS for 15 min, rinsed twice with PBS, embedded in "Neg-50" frozen section medium (Richard Allen Scientific, Kalamazoo, MI), frozen in propane that was liquefied by liquid nitrogen, and sectioned perpendicular to the underlying filter membrane in a cryostat. Sections (5 m thick) were placed on chrome alum gelatin-coated glass slides, preincubated with 10% normal goat serum in PBS, and incubated overnight at 4°C with rabbit antibodies against rat ␣ENaC (dilution 1:500), rat ␤ENaC (dilution 1:1000), rat ␥ENaC (dilution 1:400), or rat ␣ subunit of Na-K-ATPase (dilution 1:8000). Binding sites of the primary antibodies were detected with Cy3-conjugated goat antirabbit IgG (Jackson ImmunoResearch Laboratories, West Grove, PA). For control of unspecific binding of primary or secondary antibodies, we performed incubations with nonimmune sera or by omitting the primary antibody. All control experiments were negative. Sections were mounted in Dako glycergel (Dako, Glostrup, Denmark), to which 2.5% 1,4-diazobicyclo(2,2,2)octane (DABCO; Sigma) was added as fading retardant. Sections were analyzed by epifluorescence with a Zeiss microscope, and images were acquired with a charge-coupled device camera.
Detection of mRNA
For reverse transcription-PCR, mCCD cl1 cells that ere grown in filter were lysed and homogenized (QIAshredder; Qiagen, Studio City, CA), and total RNA was extracted (RNeasy Mini Kit; Qiagen). A total of 250 ng of reverse-transcribed total RNA at 37°C for 1 h using the Superscript II (Invitrogen) was amplified by PCR. The same quantity of reverse transcription mix in the absence of the enzyme was used as a negative control. ENaC and Na,K-ATPase subunit cDNA were amplified for 30 cycles in 50 l of total volume that contained 2.5 U of TaqDNA Polymerase (Amersham Biosciences) and 10 pmol of specific primers. Annealing temperature was 58°C. The primers used were ␣ENaC 5Ј-CGGAGTTGCTAAACTCAACATC-3Ј (sense) and 5Ј-TG-GAGACCAGTACCGGCT-3Ј (antisense), ␤ENaC 5Ј-ATGTGGTTCCT-GCTTACGCTG-3Ј (sense) and 5Ј-GTCCTGGTGGTGTTGCTGTG-3Ј (antisense), ␥ENaC 5Ј-CCAAAGCCAGCAAATAAACAAA-3Ј (sense) and 5Ј-GCGGCGGGCAATAATAGAGA-3Ј (antisense), Na,K-ATPase ␣1 5Ј-CCATCGCTTACACCCT-3Ј (sense) and 5Ј-CAGACGCTCGTT-CACA-3Ј (antisense), and Na,K-ATPase ␤1 5Ј-GCCCCTAAGTATTGCCG-3Ј (sense) and 5Ј-TGGGCCGTTACCTTTG-3Ј (antisense). MR, GR, and 11␤-HSD 2 cDNA were amplified using the QuantiTect SYBR Green PCR kit (Roche) as recommended by the manufacturer. Amplification was done on a LightCycler (Roche), and cDNA were amplified for 60 cycles in 20 l of total volume; annealing temperature was 55°C. The primers used were MR 5Ј-ATAGAGGCTCAAGGTCACAC-3Ј (sense) and 5Ј-GAGAAGAACGCTC-CAAGGTC-3Ј (antisense), GR 5Ј-GGGCTATGAACTTCGCAG-3Ј (sense) and 5Ј-CATCGGAGCACACCAG-3Ј (antisense), and 11␤-HSD2 5Ј-ACTGCGT-GACCTCTGT-3Ј (sense) and 5Ј-CTTGCGGAAAGTCGCC-3Ј (antisense). 
Statistical Analyses
Results are given as means Ϯ SEM for n experiments. Statistical differences between groups were calculated using t test.
Results
General Features of the Sodium Transport Response in mCCD cl1 Cells
As shown in Figure 1 , the mCCD cl1 cells had a baseline short-circuit current at approximately 10 Amps/cm 2 , which remained stable over a 6-h incubation. Upon maximal stimulation by aldosterone (300 nM; Figure 1A) , the short-circuit current increased rapidly to reach maximal value after 5 to 6 h (Ͼ30 Amps/cm 2 ). In the presence of actinomycin D (2 g/ml), the aldosterone response was fully inhibited and indistinguishable from the actinomycin D-treated control cells. Figure 1D ), the sodium transport peaked at 3 h, reaching approximately 35% of the response observed at 300 nM aldosterone, and then progressively declined to control levels. Actinomycin D fully inhibited the response. These data indicate that the aldosterone response is critically dependent on the genomic action of aldosterone, as it has been shown in a variety of experimental models in vivo (18) and in vitro (see review in (1)). As shown above in Figure 1 , A and D, the pattern of aldosterone response differs dramatically at low (0.3 nM; Figure 1D ) versus supramaximal concentrations (300 nM; Figure  1A ). As shown in Figure 1 , B and E, the pattern of corticosterone response is also time and dose dependent. At 300 nM corticosterone ( Figure 1B) , the sodium transport response peaked at 3 h and then decreased progressively toward baseline controls. At 0.3 nM corticosterone ( Figure 1E ), there was no significant sodium transport response at any time. As shown in Figure 1 , C and F, the pattern of dexamethasone response is different from that of aldosterone or corticosterone. At 300 nM dexamethasone ( Figure 1C) , the sodium transport response peaked at 6 h and remained at almost the same level for the next 21 h. At 0.3 nM dexamethasone ( Figure 1F) , there was no significant sodium transport response at any given time. Table  1 summarizes the P D , I sc , and R values of all experiments performed in the course of this study at low (0.3 nM) versus high (300 nM) aldosterone concentration. The mCCD cl1 cells have been so far passaged, up to 40 times. The aldosterone responsiveness was maintained at high passage numbers. The early response at low aldosterone concentrations was consistently between 20 and 35% of the maximal response observed at 300 nM. Experiments of the present study were performed on cells from p19 to p33.
The observed electrogenic sodium transport was amiloride sensitive (Figure 2A ). Increasing concentrations of amiloride from 0.01 to 10 M progressively and fully inhibited both the baselineand the aldosterone-stimulated sodium transport. In the presence of 140 mM sodium, the Ki for amiloride was 650 nM, not statistically different from the inhibition of aldosterone-stimulated so- In the CCD, the electrogenic amiloride-sensitive sodium transport is mediated by ENaC localized at the apical membrane and Na,K-ATPase localized at the basolateral membrane. As shown in Figure 2B , aldosterone (300 nM, 3 h) elicited an increased localization of ␣, ␤, and ␥ ENaC subunits at the apical membrane of the cells, whereas the Na,K-ATPase decorated the basolateral membrane and was not influenced by aldosterone treatment. Reverse transcription-PCR revealed that mCCD cl1 cells express not only ENaC and Na,K-ATPase but also MR, GR, and 11␤-HSD2 ( Figure 2C ).
Dose-Response Curves for Mineralo-and Glucocorticoid Agonists Aldosterone, Corticosterone, and Dexamethasone
Next, dose-response curves for the three agonists (aldosterone, corticosterone, and dexamethasone) were performed over a large range of concentrations (0.01 to 300 nM) to cover the full range of receptor occupancy by the two ligands on MR or GR. As shown in Figure 3 , ALDO left, the dose-response curve varies depending on the time of exposure to aldosterone. At 3 h and 6 h, the dose-response (Figure 3 , top and middle left) is biphasic. As shown in Table 2 , two K 1/2 can be derived from the data: The first at 0.5 nM and the second one at 89 nM. At 24 h (Figure 3 , ALDO bottom left, and Table 2), the response elicited by low dose of aldosterone had greatly diminished (K 1/2 ϭ approximately 0.65 nM) or vanished (see Figure 1A) ; the remainder of the response was characterized by a K 1/2 that progressively shifted to the right: 95 nM (6 h) and over (not determined) at 24 h.
As shown in Figure 3 (CORT top, and Table 2) , at 3 h, corticosterone induced a sodium response that was significantly shifted to the right with at least 40-fold less potency (K 1/2 ϭ approximately 18 nM). At 6 h, the responses to corticosterone were small (K 1/2 ϭ approximately 160 nM) and became NS with respect to controls at 24 h (Figure 3 , CORT middle and bottom). As shown below, this is likely to be due to the presence of 11␤-HSD2, which is able to metabolize corticosterone (which binds with high affinity to both MR and GR) to 11␤-dehydrocorticosterone, which has a very low affinity for either MR or GR. As shown in Figure 3 (DEX top, and Table 2) , at 3 h, the dose-response curve to the potent glucocorticoid agonist dexamethasone was monophasic with a K 1/2 of 10 nM, which shifted to the right after 6 h (K 1/2 ϭ approximately 20 nM; Figure 3 , DEX middle) and even more so after 24 h (Figure 3 , DEX bottom) of incubation (K 1/2 Ͼ300 nM). This is also likely to be due to dexamethasone metabolism (see below). The cell line does respond to low concentrations of aldosterone, whereas dexamethasone has no effect. To confirm this observation, we performed an additional experiment in which we compared the dose-response curve for aldosterone and dexamethasone in the same set of dishes. As shown in Figure 4A , the expected effect of low versus high doses of aldosterone or dexamethasone were observed over a 24-h incubation. The difference of the dose-response curves for the two agonists is evident during the early phase (3 h) of aldosterone action ( Figure 4B) . The difference disappeared in a time-dependent manner, and after a 24-h incubation, dexamethasone became an even more potent agonist than aldosterone ( Figure 4C ).
Evidence for Protection of MR by 11␤-HSD2
As shown in Figure 5A , corticosterone or dexamethasone alone (1 nM) had no detectable effect on sodium transport over a 6-h incubation, whereas aldosterone (1 nM) elicited a robust response. As shown in Figure 5B , carbenoxolone (10 M), a potent inhibitor of 11␤-HSD2, did not decrease baseline sodium transport. In the presence of carbenoxolone, corticosterone (and to some extent dexamethasone) induced a sodium transport response that was indistinguishable from that of aldosterone. As shown in Figure 5 , C (3 h) and D (6 h), in the presence of carbenoxolone, corticosterone elicited a sodium transport response with a K 1/2 similar to that of aldosterone alone (see Figure 4A) . Overall, the mCCD cl1 cell seems to express all of the mechanisms described in vivo to confer mineralocorticoid specificity.
Mineralo-and Glucocorticoid Specificity of the Sodium Transport Response
The mineralocorticoid specificity was examined further by investigating the effect of spironolactone, an MR antagonist, and of RU 486, a GR antagonist, during the early phase of agonist action (3 h). As shown in Figure 6A , spironolactone alone had no effect on baseline sodium transport at concentrations below 10 M. RU486 had no significant agonist activity, up to 30 M ( Figure 6B ). In subsequent experiments, the concentration of spironolactone/RU486 was kept below 1 M.
As shown in Figure 7A , a 100-fold excess of spironolactone fully inhibited the aldosterone response at 0.3, 1, 3, and 10 nM of aldosterone. By contrast, the aldosterone response within the same range of concentrations was not inhibited by a 100-fold excess of RU486 ( Figure 7B ). There was even a synergism (between 0.1 and 1 nM aldosterone) for which we have no explanation. The response to dexamethasone was not inhibited by spironolactone ( Figure 7C ) but was fully inhibited by RU486 ( Figure 7D ).
Determination of MR and GR K d and B max for Aldosterone, Corticosterone, and Dexamethasone by Equilibrium Binding Assay
The affinity and the number of sites for the three agonists used in this study were determined by equilibrium binding assay on cytosol from cells that were grown either on plastic or on transwell filter cups, as described in the Materials and Methods section, and the data are displayed as Scatchard plots (Figure 8 ). Using the Ligand program, the best fit was for a five-parameter model with two specific sites and one nonspecific component (Table 3) . Aldosterone binds with high affinity to a site that displays the properties of MR (K d 1 0.6 nM, N max 1 20 fmol/mg protein) and to a site with the Table 3 , the properties of aldosterone binding in mCCD cl1 cells that were grown on permeable supports are similar to those described above.
Discussion
A variety of ex vivo and in vitro models derived from Xenopus kidney (A6 cell line), toad urinary bladder, rat cortical collecting duct (RCCD cell lines), mouse kidney (M1), and mouse collecting duct (mpkCCDc14) (19 -25) have been used to determine the effects of corticosteroids on sodium transport in tight epithelia. However, these studies were hampered by the fact that most of these cell systems do not express significant levels of functionally active MR and most of the described effects can be ascribed only to occupancy of the GR.
The mCCD clonal cell line (mCCD cl1 ) that we report here has some novel and interesting features that made it ideally suitable for the aim of the present study. Between passages 19 and 35, the cells became more responsive to aldosterone and the dose-response curve became biphasic, indicating two K 1/2 , one at approximately 0.5 nM and the other one at approximately 90 nM. The sodium currents (reaching up to 100 Amp/cm 2 under maximal aldosterone stimulation) are completely inhibited by amiloride ( Figure 1B) , and, in fact, amiloride induced a reversal of the short-circuit current that is mediated by potassium secreted into the apical medium (26) . As shown here, the mCCD cl1 cells express both MR and GR, which can be quantified by binding equilibrium assays, therefore allowing the correlation between MR and GR occupancy versus the sodium transport response.
Mineralocorticoid Specificity
The main working hypothesis to explain aldosterone specificity of binding and action in target cells such as kidney, toad bladder, and colon in vivo, in the presence of 100-to 1000-fold molar excess of circulating glucocorticoid, proposes that the 11␤-HSD2 enzyme protects MR from exposure to glucocorticoid by rapidly converting cortisol (or corticosterone in rodents) into cortisone (or 11␤-dihydroxy-corticosterone), their respective inactive metabolites (27) . From this point of view, the A6 kidney cell is not an appropriate model for the mammalian kidney, because there is no evidence for expression of an active 11␤-HSD2 enzyme in the cell line, suggesting that MR might be protected by other mechanisms, in vitro or in vivo (28) . The TBM cell line responds equally well to aldosterone and corticosterone, indicating that endogenous 11␤-HSD2 is expressed at low level in TBM cells (29) . To our knowledge, the presence of 11␤-HSD2 in M1 cells or rCCD2 has not been described. mpkCCD cells, however, do express 11␤-HSD2 activity, albeit at a lower level than mCCD cl1 cells, as shown by a transient sodium transport response upon corticosterone stimulation (30) . The early phase of the sodium transport response, however, was indistinguishable from the aldosterone response, suggesting that the capacity (V max ) of the endogenous enzyme was not sufficient to metabolize corticosterone rapidly enough. The mCCD cl1 cell line seems to display a higher activity of 11␤-HSD2, because no sodium transport response is observed with concentrations of corticosterone up to 100 nM. By contrast, in the presence of carbenoxolone, which inhibits 11␤-HSD2, the sodium transport is restored and displays the same pattern and affinity as for aldosterone. It is interesting that dexamethasone response (at low concentrations) was restored in the presence of carbenoxolone, suggesting that dexamethasone was converted into its 11-keto metabolite. 11-Keto-dexamethasone was shown recently to bind to GR with a comparable affinity (31) and very low affinity to MR. Transactivation of MR by dexamethasone or 11-keto-dexamethasone was weak or undetectable (31) . 11␤-HSD2 protected MR and GR from illicit occupation by cortisol but is unable to prevent activation of GR by 11-keto-dexamethasone. This provides more evidence for GR-mediated sodium transport.
Occupancy of GR and MR versus Sodium Transport Response: Physiologic and Pathophysiologic Implications
The cell line developed here is ideal to establish a quantitative relationship between MR and GR occupancy and the sodium transport response to various mineralocorticoid and glucocorticoid agonists.
Early Phase of Aldosterone Action: Implications in the Circadian Regulation of Sodium and Water Balance.
Our data demonstrate clearly that the early phase of aldosterone action can be fully induced by low concentrations of aldosterone (between 30 pM and 1 nM, K 1/2 approximately 0.5 nM). This early response peaks at approximately 3 h and represents 20 to 35% of the maximal response observed under maximal hormonal concentration. It is interesting that this early response is transient, and, after 12 h, the sodium transport response tends to go back to control level. This seems not to be related to aldosterone metabolism in the target cell because addition of fresh hormone at 24 h was unable to elicit a significant sodium transport response (data not shown). The early phase of aldosterone action can be accounted for mainly by the occupancy of MR; the 200-fold difference in K d between MR and GR does not prevent some overlap of binding, and, at any given aldosterone concentration, it is expected that some GR will be occupied (between 0.5 and 2%). It is not yet possible to say what is the physiologic importance of this binding; we provide here, however, pharmacologic evidence that the early phase of the physiologic response observed at low aldosterone concentration is fully blocked by spironolactone but not by the glucocorticoid antagonist RU486. It is interesting that a low dose of dexamethasone does not induce a sodium transport response comparable to that of aldosterone. By contrast, a high glucocorticoid concentration leads to an early and late effect, which is well maintained over 24 h of incubation. These observations have an implication in the circadian regulation of sodium and water balance. In humans (32) and rodents (33, 34) , plasma cortisol (corticosterone) and plasma aldosterone vary according to a circadian rhythm. Circadian rhythm of adrenal secretion of aldosterone and cortisol (or corticosterone in rodents) mediating sodium reabsorption in kidney and colon is maintained, independent of salt intake and activity (35) , to adjust day and night the sodium balance. If the in vitro data obtained in the present study can be extrapolated to in vivo, then it is possible to predict the occupancy of MR and GR according to the hormonal profiles that have been published for rat or mice ( Figure 9 ). The rapid and reversible action of aldosterone on ENaC activity is made possible by the rapid regulation of ENaC trafficking, achieved by posttranslational mechanisms implicating Sgk1 and Nedd4 -2.
Long-Term Regulation under Chronic Salt Restriction. Plasma aldosterone has been reported to raise to high values in rats (36, 37) under chronic salt restriction or in salt-losing mice (38) . Under these circumstances, the plasma corticosterone is normal or slightly elevated. According to our model, the MR would be occupied approximately 95% and GR up to approximately 60% by aldosterone. This dual occupancy is expected to mediate the late phase of aldosterone action on sodium transport, which will be maintained as long as high concentrations of aldosterone would be maintained. Corticosterone under these circumstances will still be fully metabolized by 11␤-HSD2 and thus plays little role in sodium balance. Dexamethasone, as well as its 11-keto metabolite, which binds preferentially to GR, can also elicit the sodium transport. At 10 nM dexamethasone, 50% of GR would be occupied, close to the EC50 for the sodium transport observed at 24 h.
Acute Regulation under Stress. Under stress, the situation may be different, and free cortisol (or corticosterone) may reach a level (up to 150 nM) that may well overcome the capacity of 11␤-HSD2 (39, 40) . If we assume that free corticosterone in rodents will vary within the same range, then the 11␤-HSD2 capacity may very well be surpassed and corticosterone will begin to occupy a significant proportion of MR and GR, contributing to the rapid regulation of all genes under the control of MR and GR.
Finally, our data suggest that the regulation of the transcriptome in the principal cell should now be investigated in a timeand dose-dependent manner to define the gene network that is more specifically linked to MR occupancy versus that which is related to occupancy of MR and GR by aldosterone and/or corticosterone. Until now, no hormonal regulatory elements specific to MR but only elements specific to GR have been identified in the promoter of induced or repressed genes. Mineralocorticoid specificity therefore is achieved by different mechanisms: At the prereceptor level (11␤-HDSD2), at the receptor level, and at the level of transcription activation or repression (cell specific co-factor) (27) . These molecular mechanisms are difficult to study in vivo because of the great heterogeneity of the kidney. Our clonal cell line should provide a tool first to identify in vitro the basic mechanisms of the transcriptional machinery of the principal cell. Table 3 and is shown on the y axis as a function of aldosterone concentration (x axis). (Bottom) Sodium transport as measured by I sc (y axis) as a function of aldosterone concentration (x axis). The dose-response curves measured at 3 h (OE) and at 24 h (f) are shown. Plasma aldosterone concentration and free plasma cortisol/corticosterone (see references in the Discussion section) during circadian rhythm, salt restriction, and stress are indicated to predict receptor occupancy (dashed vertical lines) at different hormonal concentrations. The degree of MR/GR protection by 11␤-HSD2 is indicated, according to the in vitro data of the present study.
